Santhera Pharmaceuticals Holding AG (SANN) — Capital Reinvestment Ratio
Santhera Pharmaceuticals Holding AG (SANN) has a Capital Reinvestment Ratio of 0.00x as of December 2023, meaning it reinvests 0% of its operating cash flow (CHF62.63 Million) in capital expenditures (CHF90.00K). See SANN free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Santhera Pharmaceuticals Holding AG Capital Reinvestment Ratio (2019–2023)
This chart tracks Santhera Pharmaceuticals Holding AG's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for Santhera Pharmaceuticals Holding AG (2019–2023)
Year-by-year Capital Reinvestment Ratio for Santhera Pharmaceuticals Holding AG from 2019 to 2023. For live market cap and broader valuation context, see Santhera Pharmaceuticals Holding AG (SANN) total market value.
| Year | Reinvestment Ratio | Operating CF (CHF) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.50x | CHF47.27 Million | CHF23.74 Million | ▲ +469.2% |
| 2019 | 0.09x | CHF2.60 Million | CHF229.00K | — |